Skip to main content

Series A · 2026-11-18 · AI

Boltz raises $110.0M

76
AI Score
Amount
$110.0M
Round
Series A
Lead
Bessemer
HQ
—
Why it matters: Boltz's $110M Series A shows investors backing domain-specific drug discovery models, with details on how BoltzMol-1 cuts candidate screening from hundreds of thousands of molecules to a few dozen.

Boltz PBC, a startup building AI models for pharmaceutical research, raised a $110 million Series A led by Bessemer.

Participants:
Andreessen Horowitz, Amplify Partners, Zetta Venture Partners, Obvious Ventures, Greycroft, F-Prime Capital, Hummingbird, Benchling

Deal Dossier PRO

Pro feature
Deal Dossier for Boltz

Company, lead and participating investors, founders, and verified public contact channels — sourced, generated on demand.

Generate dossier — Pro
Already Pro? Sign in · See plans

Figures marked company-reported are unaudited. Not investment advice. Request a correction or removal (team@midu.si).

More deals with Bessemer

Recent AI rounds

Browse all deals in the funding database →

Subscribe to the newsletters

Free, by email. No account needed. Pick one or both.

No spam. Unsubscribe anytime by emailing team@midu.si. Want alerts and full data? Sign up free (separate from the newsletter). Privacy.

Not investment advice. Midu summarizes public reports and SEC filings for information only. · Free API · Pricing